Yahoo Finance 
North America Breast Reconstruction Market Forecasted to Reach USD 366.2 Million by 2030 Amid Surge in Breast Cancer Cases
North American Breast Reconstruction Market
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "North America Breast Reconstruction Market Size, Share & Trends Analysis Report By Product (Implant, Tissue Expander, Acellular Dermal Matrix), By Shape (Round Shape, Anatomical Shape), By End-use, By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
The North America breast reconstruction market is projected to experience significant growth with an expected worth of USD 366.2 million by the year 2030, which translates to a compound annual growth rate (CAGR) of 6.8% from 2023 to 2030. A major factor contributing to this growth is the rising number of breast cancer cases in the region.
The market is segmented by product, shape, and end-use. In 2022, the implants segment dominated the market, claiming a substantial share due to its widespread acceptance for breast reconstruction post-mastectomy. Notably, tissue expanders are gaining popularity thanks to innovative advancements, making them the segment with the anticipated highest growth rate during the forecast period.
Trends Within Market Shapes
In terms of the shape of breast implants, the market has traditionally been led by round-shaped implants. However, anatomical-shaped implants are expected to see an accelerated growth pattern, indicating a shift in market preferences and technology.
End-Use Preferences
Hospitals held the lion's share of the market in 2022, but cosmetology clinics are on the rise. With a projected CAGR of 7.0%, cosmetology clinics' growth is tied to the increasing number of professionals in the field across North America.
Regional Insights
The United States remains the preeminent market within the region, supported by a high volume of breast cancer cases and surgical procedures. This data underscores the importance of the U.S. market to North America's overall market dynamics for breast reconstruction.
COVID-19 Impact and Industry Response: The pandemic initially dampened market growth due to deferred elective procedures. Nonetheless, the post-pandemic outlook is optimistic as postponed surgeries are expected to resume.
Awareness Campaigns: Initiatives such as the Breast Reconstruction Awareness Campaign are empowering more women to make informed decisions regarding their post-breast cancer surgical options, further expanding market potential.
Market Partnerships: Strategic alliances are forming within the industry, as evidenced by Sientra, Inc.'s partnership with Butterfly Network, aimed at improving patient outcomes and enhancing product safety profiles.
Key Attributes:
Report Attribute | Details |
No. of Pages | 90 |
Forecast Period | 2022 - 2030 |
Estimated Market Value (USD) in 2022 | $218.1 Million |
Forecasted Market Value (USD) by 2030 | $366.2 Million |
Compound Annual Growth Rate | 6.8% |
Regions Covered | North America |
Companies Mentioned
Mentor Worldwide LLC
AbbVie Inc.
Integra LifeSciences
Sientra, Inc.
Stryker
Establishment Labs
RTI Surgical
MTF Biologics
Surgical Innovation Associates
TELA Bio, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/9z2w0w
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
